$6.88 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
$16.19 - $25.77The lowest and highst price in the last 52 weeks.
73.17xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
$0.00 (0.0%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
|Market Cap||$6.88 Billion|
|Enterprise Value||$5.53 Billion|
|Dividend Yield||$0.00 (0.0%)|
|1 Year Return||-7.4%|
|Outstanding Shares||315 Million|
|Avg 30 Day Volume||1.6 Million|
|Earnings per Share||$0.29|
|Price to Sales Ratio||7.28|
|Price to Book Ratio||3.64|
|Revenue to Enterprise Value||4.78|
|EBIT to Enterprise Value||55.28|
|Total Debt to Enterprise Value||0.0|
|Debt to Equity||0.0|
|Gross Profit||$1.11 Billion|
|Net Income||$94 Million|
|Quarterly Earnings Growth (YoY)||+43.8%|
|Return on Equity||4.6%|
|Return on Assets||3.97%|
|Return on Invested Capital||4.74%|
234,097 shares sold (5 transactions)
149,557 shares sold (7 transactions)
115,000 shares sold (2 transactions)
Kwhen Finance, 5 days ago
Exelixis Inc. (NASDAQ: EXEL) stock fell 1.08% (As on Oct 8, 12:34:50 AM UTC-4, Source: Google Finance) though Jefferies has started coverage with a Buy The post Exelixis Inc. (NASDAQ: EXEL) stock c...FXDailyReport, 10 days ago
Cancer Active Pharmaceuticals Drugs (API) is the ingredient in medical drug use for cancer. Cancer is unregulated and disordered cell development. There are five main API molecule categories includ...OpenPR, 13 days ago